Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...

Though prescribing climate-friendly inhalers is environmentally sound, some experts warn certain patients may be overlooked.

By restructuring our collaboration with GSK, we have embarked on a new chapter of growth ... banking roles at Barclays and Société Générale, as well as co-heading European healthcare investments at 3i ...

At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA, Sanofi ...

Yet in Europe things look good for the firm ... Mark Hartley has positions in AstraZeneca Plc and GSK. The Motley Fool UK has recommended AstraZeneca Plc, GSK, Rolls-Royce Plc, Tesla, and Workday.

Richard Staines heard about this new strategy at the Veeva 2019 Commercial and Medical Summit, Europe. GSK’s approach to marketing content has had a major rethink in the last two years ...